<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045388"><TermName>deferoxamine</TermName><TermPronunciation>(DEH-feh-ROK-suh-meen)</TermPronunciation><TermDefinition><DefinitionText>An iron-chelating agent that removes iron from tumors by inhibiting DNA synthesis and causing cancer cell death. It is used in conjunction with other anticancer agents in pediatric neuroblastoma therapy.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000730928" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;deferoxamine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000730929" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;deferoxamina&quot;" language="es" id="_4"/><SpanishTermName>deferoxamina</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia quelante del hierro que extrae el hierro de los tumores al impedir la síntesis del ADN y eliminar las células cancerosas. Se usa junto con otros medicamentos contra el cáncer en el tratamiento del neuroblastoma pediátrico.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition></GlossaryTerm>
